Sexually Transmitted Infection Screening in Key Populations of Persons Living with HIV.
Alcohol use disorder
Health equity
Persons living with HIV
Prevention index
Racial and ethnic minorities
Screening
Sexually transmitted infections
Women living with HIV
Journal
AIDS and behavior
ISSN: 1573-3254
Titre abrégé: AIDS Behav
Pays: United States
ID NLM: 9712133
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
accepted:
30
05
2022
pmc-release:
01
01
2024
pubmed:
3
8
2022
medline:
24
1
2023
entrez:
2
8
2022
Statut:
ppublish
Résumé
Annual screening for bacterial sexually transmitted infections (STI), including gonorrhea/chlamydia (GC/CT) and syphilis, is recommended for persons with HIV (PWH). We used the prevention index to quantify the extent to which STI screening was completed at guideline-recommended frequency in African American and Latinx persons, women, persons with alcohol (AUD) and substance (SUD) use disorders. Data from PWH at Kaiser Permanente Northern California were collected from electronic health records. We defined receipt of GC/CT and syphilis screening consistent with recommendations as a prevention index score ≥ 75%. Among 9655 PWH (17.7% Latinx; 16.2% African American; 9.6% female; 12.4% AUD; 22.1% SUD), prevention index scores for GC/CT and syphilis increased from 2015 to 2019. African American PWH had lower odds of receiving an annual syphilis screen (aOR 0.87 [95% CI 0.79-0.97]). Female sex was associated with lower odds of GC/CT (aOR 0.30 [95% CI 0.27-0.34]) and syphilis (aOR 0.27 [95% CI 0.24-0.310) screening. AUD and SUD were not associated with differences in annual GC/CT or syphilis screening. Key PWH subgroups experience ongoing challenges to annual STI screening despite comparable healthcare access.
Identifiants
pubmed: 35916949
doi: 10.1007/s10461-022-03747-w
pii: 10.1007/s10461-022-03747-w
pmc: PMC9851927
mid: NIHMS1822394
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
96-105Subventions
Organisme : NIAAA NIH HHS
ID : U01 AA021997
Pays : United States
Organisme : NIAID NIH HHS
ID : K01 AI157849
Pays : United States
Organisme : NIDA NIH HHS
ID : T32 DA007250
Pays : United States
Organisme : NIAID NIH HHS
ID : P30 AI027763
Pays : United States
Organisme : NIAAA NIH HHS
ID : K24 AA025703
Pays : United States
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2019 [Internet]. Atlanta: U.S. Department of Health and Human Services; 2021. Available from: https://www.cdc.gov/std/statistics/2019/default.htm .
Kreisel KM, Spicknall IH, Gargano JW, Lewis FMT, Lewis RM, Markowitz LE, et al. Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018. Sex Transm Dis. 2021;48(4):208–14.
doi: 10.1097/OLQ.0000000000001355
Secco AA, Akselrod H, Czeresnia J, Levy M, Byrne M, Monroe A, et al. Sexually transmitted infections in persons living with HIV infection and estimated HIV transmission risk: trends over time from the DC Cohort. Sex Transm Infect. 2020;96(2):89.
doi: 10.1136/sextrans-2019-054216
Landovitz RJ, Gildner JL, Leibowitz AA. Sexually Transmitted Infection Testing of HIV-Positive Medicare and Medicaid Enrollees Falls Short of Guidelines. Sex Transm Dis. 2018;45(1):8–13.
doi: 10.1097/OLQ.0000000000000695
Kalichman SC, Pellowski J, Turner C. Prevalence of sexually transmitted co-infections in people living with HIV/AIDS: systematic review with implications for using HIV treatments for prevention. Sex Transm Infect. 2011;87(3):183.
doi: 10.1136/sti.2010.047514
Mwatelah R, McKinnon LR, Baxter C, Karim QA, Karim SSA. Mechanisms of sexually transmitted infection-induced inflammation in women: implications for HIV risk. J Int AIDS Soc. 2019;22(S6):e25346.
doi: 10.1002/jia2.25346
Cohen MS, Council OD, Chen JS. Sexually transmitted infections and HIV in the era of antiretroviral treatment and prevention: the biologic basis for epidemiologic synergy. J Int AIDS Soc. 2019;22(S6):e25355.
doi: 10.1002/jia2.25355
Unemo M, Bradshaw CS, Hocking JS, Vries HJC de, Francis SC, Mabey D, et al. Sexually transmitted infections: challenges ahead. Lancet Infect Dis. 2017;17(8):e235–79.
doi: 10.1016/S1473-3099(17)30310-9
Palacios R, Jiménez-Oñate F, Aguilar M, Galindo MJ, Rivas P, Ocampo A, et al. Impact of Syphilis Infection on HIV Viral Load and CD4 Cell Counts in HIV-Infected Patients. J Acquir Immune Defic Syndr. 2007;44(3):356–9.
doi: 10.1097/QAI.0b013e31802ea4c6
Jarzebowski W, Caumes E, Dupin N, Farhi D, Lascaux AS, Piketty C, et al. Effect of Early Syphilis Infection on Plasma Viral Load and CD4 Cell Count in Human Immunodeficiency Virus–Infected Men: Results From the FHDH-ANRS CO4 Cohort. Arch Intern Med. 2012;172(16):1237–43.
doi: 10.1001/archinternmed.2012.2706
Weintrob AC, Gu W, Qin J, Robertson J, Ganeson A, Crum-Cianflone NF, et al. Syphilis co-infection does not affect HIV disease progression. Int J Std AIDS. 2009;21(1):57–9.
doi: 10.1258/ijsa.2009.009164
Chitneni P, Matthews LT. The Other U = U: Untested and Untreated Genital Tract Inflammation in People Living With and Exposed to Human Immunodeficiency Virus. J Infect Dis. 2021;224(1):1–4.
doi: 10.1093/infdis/jiab074
Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually Transmitted Infections Treatment Guidelines 2021 MMWR Recomm Rep. 2021;70(4):1–187.
Farley TA, Cohen DA, Elkins W. Asymptomatic sexually transmitted diseases: the case for screening. Prev Med. 2003;36(4):502–9.
doi: 10.1016/S0091-7435(02)00058-0
Detels R, Green AM, Klausner JD, Katzenstein D, Gaydos C, Handsfield HH, et al. The Incidence and Correlates of Symptomatic and Asymptomatic Chlamydia trachomatis and Neisseria gonorrhoeae Infections in Selected Populations in Five Countries. Sex Transm Dis. 2011;38(6):503–9.
doi: 10.1097/OLQ.0b013e318206c288
U.S. Department of Health and Human Services. Sexually Transmitted Infections National Strategic Plan for the United States: 2021–2025 [Internet]. Washington, DC; 2020. Available from: https://www.hhs.gov/sites/default/files/STI-National-Strategic-Plan-2021-2025.pdf .
Park IU, Reminick D, Schapiro JM, Hurley LB, Hare CB, Slome S, et al. Improved gonorrhea and chlamydia testing among men who have sex with men living with HIV through implementation of self-collected tests. Sex Transm Dis. 2021 Nov 1;48(11):e165-e167. doi: https://doi.org/10.1097/OLQ.0000000000001369 .
Chapin-Bardales J, Rosenberg ES, Sullivan PS. Trends in racial/ethnic disparities of new AIDS diagnoses in the United States, 1984–2013. Ann Epidemiol. 2017;27(5):329–34.e2.
doi: 10.1016/j.annepidem.2017.04.002
Crepaz N, Dong X, Wang X, Hernandez AL, Hall HI. Racial and Ethnic Disparities in Sustained Viral Suppression and Transmission Risk Potential Among Persons Receiving HIV Care — United States, 2014. MMWR Morbidity Mortal Wkly Rep. 2018;67(4):113–8.
doi: 10.15585/mmwr.mm6704a2
Matson TE, McGinnis KA, Rubinsky AD, Frost MC, Czarnogorski M, Bryant KJ, et al. Gender and alcohol use. AIDS. 2018;32(15):2247–53.
doi: 10.1097/QAD.0000000000001946
Williams EC, McGinnis KA, Edelman EJ, Matson TE, Gordon AJ, Marshall BDL, et al. Level of Alcohol Use Associated with HIV Care Continuum Targets in a National U.S. Sample of Persons Living with HIV Receiving Healthcare. AIDS Behav. 2019;23(1):140–51.
doi: 10.1007/s10461-018-2210-6
Gonzalez A, Barinas J, O’Cleirigh C. Substance use: impact on adherence and HIV medical treatment. Curr HIV/AIDS Rep. 2011;8(4):223–34.
doi: 10.1007/s11904-011-0093-5
Vogt TM, Feldstein AC, Aickin M, Hu WR, Uchida AR. Electronic Medical Records and Prevention Quality The Prevention Index. Am J Prev Med. 2007;33(4):291–6.
doi: 10.1016/j.amepre.2007.05.011
Hatch BA, Tillotson CJ, Huguet N, Hoopes MJ, Marino M, DeVoe JE. Use of a Preventive Index to Examine Clinic-Level Factors Associated With Delivery of Preventive Care. Am J Prev Med. 2019;57(2):241–9.
doi: 10.1016/j.amepre.2019.03.016
Vogt TM, Aickin M, Ahmed F, Schmidt M. The Prevention Index: Using Technology to Improve Quality Assessment. Health Serv Res. 2004;39(3):511–30.
doi: 10.1111/j.1475-6773.2004.00242.x
Gordon NP. Similarity of adult Kaiser Permanente members to the adult population in Kaiser Permanente’s Northern California service area: Comparisons based on the 2017/2018 cycle of the California Health Interview Survey. 2020. Available from: https://divisionofresearch.kaiserpermanente.org/projects/memberhealthsurvey/SiteCollectionDocuments/compare_kp_ncal_chis2017-18.pdf .
Silverberg MJ, Chao C, Leyden WA, Xu L, Tang B, Horberg MA, et al. HIV infection and the risk of cancers with and without a known infectious cause. AIDS. 2009;23(17):2337–45.
doi: 10.1097/QAD.0b013e3283319184
Messer LC, Laraia BA, Kaufman JS, Eyster J, Holzman C, Culhane J, et al. The development of a standardized neighborhood deprivation index. J Urban Health. 2006;83(6):1041–62.
doi: 10.1007/s11524-006-9094-x
Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, et al. Preexposure Prophylaxis for HIV Prevention in a Large Integrated Health Care System: Adherence, Renal Safety, and Discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–6.
doi: 10.1097/QAI.0000000000001129
Stata. Contrast [Internet]. [cited 2022 Apr 6]. Available from: https://www.stata.com/manuals/rcontrast.pdf .
Centers for Disease Control and Prevention. Health Disparities in HIV/AIDS, Viral Hepatitis, STDs, and TB [Internet]. 2020. Available from: https://www.cdc.gov/nchhstp/healthdisparities/africanamericans.html .
Datta J, Reid D, Hughes G, Mercer CH, Wayal S, Weatherburn P. Places and people: the perceptions of men who have sex with men concerning STI testing: a qualitative study. Sex Transm Infect. 2018;94(1):46.
doi: 10.1136/sextrans-2016-052983
Aral SO, Adimora AA, Fenton KA. Understanding and responding to disparities in HIV and other sexually transmitted infections in African Americans. Lancet. 2008;372(9635):337–40.
doi: 10.1016/S0140-6736(08)61118-6
Gamble VN. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health. 1997;87(11):1773–8.
doi: 10.2105/AJPH.87.11.1773
Levy ME, Wilton L, Phillips G, Glick SN, Kuo I, Brewer RA, et al. Understanding Structural Barriers to Accessing HIV Testing and Prevention Services Among Black Men Who Have Sex with Men (BMSM) in the United States. AIDS Behav. 2014;18(5):972–96.
doi: 10.1007/s10461-014-0719-x
Ojikutu BO, Bogart LM, Higgins-Biddle M, Dale SK, Allen W, Dominique T, et al. Facilitators and Barriers to Pre-Exposure Prophylaxis (PrEP) Use Among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC). AIDS Behav. 2018;22(11):3576–87.
doi: 10.1007/s10461-018-2067-8
Force UPST, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Screening for Chlamydia and Gonorrhea. JAMA. 2021;326(10):949–56.
doi: 10.1001/jama.2021.14081
Kreisel KM, Weston EJ, Cyr SBS, Spicknall IH. Estimates of the Prevalence and Incidence of Chlamydia and Gonorrhea Among US Men and Women, 2018. Sex Transm Dis. 2021;48(4):222–31.
doi: 10.1097/OLQ.0000000000001382
Dionne-Odom J, Westfall AO, Pol BVD, Fry K, Marrazzo J. Sexually Transmitted Infection Prevalence in Women With HIV. Sex Transm Dis. 2018;45(11):762–9.
doi: 10.1097/OLQ.0000000000000852
Manhart LE, Marrazzo JM, Fine DN, Kerani RP, Golden MR. Selective Testing Criteria for Gonorrhea among Young Women Screened for Chlamydial Infection: Contribution of Race and Geographic Prevalence. J Infect Dis. 2007;196(5):731–7.
doi: 10.1086/520517
Dionne-Odom J, Westfall AO, Dombrowski JC, Kitahata MM, Crane HM, Mugavero MJ, et al. Intersecting Epidemics: Incident Syphilis and Drug Use in Women Living with HIV in the United States (2005–2016). Clin Infect Dis. 2019;71(9):2405–13.
Hull S, Kelley S, Clarke JL. Sexually Transmitted Infections: Compelling Case for an Improved Screening Strategy. Popul Health Manag. 2017;20(S1):–111.
Cuffe KM, Newton-Levinson A, Gift TL, McFarlane M, Leichliter JS. Sexually Transmitted Infection Testing Among Adolescents and Young Adults in the United States. J Adolesc Health. 2016;58(5):512–9.
doi: 10.1016/j.jadohealth.2016.01.002
Duko B, Ayalew M, Ayano G. The prevalence of alcohol use disorders among people living with HIV/AIDS: a systematic review and meta-analysis. Subst Abus Treat Prev Policy. 2019;14(1):52.
doi: 10.1186/s13011-019-0240-3
Hartzler B, Dombrowski JC, Crane HM, Eron JJ, Geng EH, Mathews WC, et al. Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States. AIDS Behav. 2017;21(4):1138–48.
doi: 10.1007/s10461-016-1584-6
Scott-Sheldon LAJ, Walstrom P, Carey KB, Johnson BT, Carey MP, Team MR. Alcohol Use and Sexual Risk Behaviors among Individuals Infected with HIV: A Systematic Review and Meta-Analysis 2012 to Early 2013. Curr HIV/AIDS Rep. 2013;10(4):314–23.
doi: 10.1007/s11904-013-0177-5
Shuper PA, Joharchi N, Irving H, Rehm J. Alcohol as a Correlate of Unprotected Sexual Behavior Among People Living with HIV/AIDS: Review and Meta-Analysis. Aids Behav. 2009;13(6):1021–36.
doi: 10.1007/s10461-009-9589-z
Ostrow DG, Plankey MW, Cox C, Li X, Shoptaw S, Jacobson LP, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.
doi: 10.1097/QAI.0b013e3181a24b20
Vosburgh HW, Mansergh G, Sullivan PS, Purcell DW. A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men. AIDS Behav. 2012;16(6):1394–410.
doi: 10.1007/s10461-011-0131-8
Shuper PA, Johrachi N, Monti PM, Loutfy M, Rehm J. Acute Alcohol Consumption Directly Increases HIV Transmission Risk: A Randomized Controlled Experiment. J Acquir Immune Defic Syndr. 2017 Dec 15; 76(5): 493–500.
Scott-Sheldon LAJ, Carey KB, Cunningham K, Johnson BT, Carey MP, MASH Research Team. Alcohol Use Predicts Sexual Decision-Making: A Systematic Review and Meta-Analysis of the Experimental Literature. AIDS Behav. 2015;20(S1):19–39.
doi: 10.1007/s10461-015-1108-9
Monroe AK, Lau B, Mugavero MJ, Mathews WC, Mayer KC, Napravnik S, et al. Heavy Alcohol Use is Associated with Worse Retention in HIV Care. J Acquir Immune Defic Syndr. 2016;73(4):419–25.
doi: 10.1097/QAI.0000000000001083
Zhang Y, Wilson TE, Adedimeji A, Merenstein D, Milam J, Cohen J, et al. The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States. AIDS Behav. 2018;22(3):896–908.
doi: 10.1007/s10461-017-1808-4
Azar MM, Springer SA, Meyer JP, Altice FL. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.
doi: 10.1016/j.drugalcdep.2010.06.014
Satre DD, Levine-Hall T, Sterling SA, Young-Wolff KC, Lam JO, Alexeeff S, et al. The relationship of smoking and unhealthy alcohol use to the HIV care continuum among people with HIV in an integrated health care system. Drug Alcohol Depen. 2021;219:108481.
doi: 10.1016/j.drugalcdep.2020.108481
Scarborough AP, Slome S, Hurley LB, Park IU. Improvement of Sexually Transmitted Disease Screening Among HIV-Infected Men Who Have Sex With Men Through Implementation of a Standardized Sexual Risk Assessment Tool. Sex Transm Dis. 2015;42(10):595–8.
doi: 10.1097/OLQ.0000000000000333